Functional Outcomes of Single-Stage Ossiculoplasty in Chronic Otitis Media With or Without Cholesteatoma.

IF 1 4区医学 Q3 OTORHINOLARYNGOLOGY

Journal of International Advanced Otology Pub Date : 2022-09-01 DOI:10.5152/iao.2022.21360

Seongbin Park, Kang Hyeon Lim, Sung Jin Lim, Dong Heun Park, Yoon Chan Rah, June Choi

{"title":"Functional Outcomes of Single-Stage Ossiculoplasty in Chronic Otitis Media With or Without Cholesteatoma.","authors":"Seongbin Park, Kang Hyeon Lim, Sung Jin Lim, Dong Heun Park, Yoon Chan Rah, June Choi","doi":"10.5152/iao.2022.21360","DOIUrl":null,"url":null,"abstract":"Background: Two-stage ossiculoplasty has been widely used for hearing improvement in chronic otitis media with or without cholesteatoma. However, the outcomes of single-stage ossiculoplasty have not been fully clarified.The aim of this study is to determine whether the outcomes of single-stage ossiculoplasty are comparable with those of 2-stage ossiculoplasty in chronic otitis media with or without cholesteatoma.Methods: Medical records of 191 cases (187 patients) who underwent single-stage ossiculoplasty from January 2011 to May 2018 at our hospital were retrospectively reviewed.Results: Polycel and titanium were used in 56 and 135 cases, respectively. In chronic otitis media without cholesteatoma, the success rate of polycel and titanium partial ossicular replacement prosthesis was 80.7% and 81.6%, respectively. In chronic otitis media with cholesteatoma, the success rate of polycel and titanium partial ossicular replacement prosthesis was 63.6% and 64.6%, respectively, while that of polycel and titanium total ossicular replacement prosthesis was 45.9% and 47.8%, respectively.Conclusion: These results suggest that single-stage ossiculoplasty is a suitable option for recovering postoperative hearing in chronic otitis media with or without cholesteatoma. Thus, if middle ear inflammation can be sufficiently treated in the first stage, single-stage ossiculoplasty is a suitable option for chronic otitis media with or without cholesteatoma.","PeriodicalId":54793,"journal":{"name":"Journal of International Advanced Otology","volume":"18 5","pages":"415-419"},"PeriodicalIF":1.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/ed/jiao-18-5-415.PMC9524377.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Advanced Otology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/iao.2022.21360","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 3

Abstract

Background: Two-stage ossiculoplasty has been widely used for hearing improvement in chronic otitis media with or without cholesteatoma. However, the outcomes of single-stage ossiculoplasty have not been fully clarified.The aim of this study is to determine whether the outcomes of single-stage ossiculoplasty are comparable with those of 2-stage ossiculoplasty in chronic otitis media with or without cholesteatoma.

Methods: Medical records of 191 cases (187 patients) who underwent single-stage ossiculoplasty from January 2011 to May 2018 at our hospital were retrospectively reviewed.

Results: Polycel and titanium were used in 56 and 135 cases, respectively. In chronic otitis media without cholesteatoma, the success rate of polycel and titanium partial ossicular replacement prosthesis was 80.7% and 81.6%, respectively. In chronic otitis media with cholesteatoma, the success rate of polycel and titanium partial ossicular replacement prosthesis was 63.6% and 64.6%, respectively, while that of polycel and titanium total ossicular replacement prosthesis was 45.9% and 47.8%, respectively.

Conclusion: These results suggest that single-stage ossiculoplasty is a suitable option for recovering postoperative hearing in chronic otitis media with or without cholesteatoma. Thus, if middle ear inflammation can be sufficiently treated in the first stage, single-stage ossiculoplasty is a suitable option for chronic otitis media with or without cholesteatoma.

Abstract Image

查看原文本刊更多论文

伴有或不伴有胆脂瘤的慢性中耳炎单期听骨成形术的功能结果。

背景:两阶段听骨成形术已被广泛用于慢性中耳炎伴或不伴胆脂瘤的听力改善。然而，单期听骨成形术的结果尚未完全明确。本研究的目的是确定在合并或不合并胆脂瘤的慢性中耳炎中，单期听骨成形术与两期听骨成形术的结果是否具有可比性。方法:回顾性分析我院2011年1月至2018年5月行单期听骨成形术191例(187例)患者的病历。结果:Polycel和钛分别用于56例和135例。在无胆脂瘤的慢性中耳炎患者中，多聚细胞和钛部分听骨置换术的成功率分别为80.7%和81.6%。慢性中耳炎合并胆脂瘤患者，多聚细胞和钛部分听骨置换术的成功率分别为63.6%和64.6%，多聚细胞和钛全听骨置换术的成功率分别为45.9%和47.8%。结论:单期听骨成形术是慢性中耳炎伴或不伴胆脂瘤患者术后听力恢复的合适选择。因此，如果中耳炎症能在第一阶段得到充分治疗，单期听骨成形术是伴有或不伴有胆脂瘤的慢性中耳炎的合适选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of International Advanced Otology OTORHINOLARYNGOLOGY-

CiteScore

1.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal of International Advanced Otology (IAO – Citation Abbreviation: J Int Adv Otol) is an open access double-blind peer-reviewed, international publication. The Journal of International Advanced Otology is fully sponsored and owned by the European Academy of Otology and Neurotology and the Politzer Society. The Journal of International Advanced Otology is published 3 times per year on April, August, December and its publication language is English. The scope of the Journal is limited with otology, neurotology, audiology (excluding linguistics) and skull base medicine. The Journal of International Advanced Otology aims to publish manuscripts at the highest clinical and scientific level. IAO publishes original articles in the form of clinical and basic research, review articles, short reports and a limited number of case reports. Controversial patient discussions, communications on emerging technology, and historical issues will also be considered for publication.